• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

E-Module

An HIV and Rehab Resource

  • Français
  • About
    • 1 – What is this resource about and who is it for?
    • 2 – Why was this resource created?
    • 3 – How can this resource be used?
    • 4 – Can this resource be used for teaching?
    • 5 – How was this resource developed?
    • 6 – Who contributed to developing this adapted resource?
    • 7 – Who funded the development of this resource?
    • 8 – Disclaimer
  • Section 1
    • 1.1 How is “rehabilitation” defined in this resource?
    • 1.2 How can rehabilitation help people living with HIV?
    • 1.3 How can the World Health Organization’s “ICF” help us think about rehabilitation for people living with HIV?
    • 1.4 How can the Episodic Disability Model help us think about rehabilitation for people living with HIV?
    • 1.5 Who provides rehabilitation for people living with HIV?
    • 1.6 Do rehabilitation providers need special skills or training to care for people living with HIV? If so, what?
    • 1.7 What roles do rehabilitation providers have related to HIV?
    • 1.8 When is rehabilitation clinical intervention useful along the HIV care continuum?
  • Section 2
    • 2.1 What do rehabilitation professionals need to know about the stages of HIV infection?
    • 2.2 What do rehabilitation providers need to know about CD4 count and viral load?
    • 2.3 What is the impact of HIV on body systems and why does this matter for rehabilitation providers?
    • 2.4 Who might rehabilitation providers treat?
    • 2.5 What do rehabilitation providers need to know about antiretroviral therapies?
  • Section 3
    • 3.1 What are the rehabilitation interventions that address impairments common among people living with HIV?
    • 3.2 What are the rehabilitation interventions that can address the activity limitations and participation restrictions common among people living with HIV?
    • 3.3 More information on the rehabilitation interventions available for people living with HIV
    • 3.4 – What do rehabilitation providers need to know about their patients’ beliefs and use of traditional healers, spiritual leaders and alternative therapies outside the formal medical system?
  • Section 4
    • 4.1: Intersectionality Theory in the Context of Rehabilitation
    • 4.2: Children and Youth
    • 4.3: HIV and Aging
    • 4.4: Substance Use
    • 4.5: Trauma
    • 4.6: Racialized Populations
    • 4.7: Indigenous Populations
    • 4.8: HIV, Sex and Gender
    • 4.9: HIV and COVID-19
    • 4.10: Is HIV itself a disability?
  • Section 5
    • 5.1 What are outcome measures?
    • 5.2 Why is it important to use outcome measures during rehabilitation with people living with HIV?
    • 5.3 How do rehabilitation providers know if an outcome measure will be useful in practice?
    • 5.4 What are floor and ceiling effects in outcome measurement?
    • 5.5 What is the difference between generic and HIV-specific outcome measures?
    • 5.6 How should you decide which outcome measures to use?
    • 5.7 How do you access a copy of an outcome measure?
    • 5.8 What are rehabilitation-related outcome measures that can be useful for people living with HIV?
  • Case Studies
    • Case #1 – Acute Care, Cardiorespiratory and Neurological
    • Case #2 – Musculoskeletal – Knee Pain
    • Case #3 – Aging, Cognition, Community, Stroke
    • Case #4 – Complex Case – Musculoskeletal, Episodic, Cardiorespiratory
    • Case #5 – Diabetes, Neuropathy, Substance Use
    • Case #6 – Transition from Paediatric to Adult Care
    • Supplemental Case Studies without Leading Questions
Hide Search
Show Search

5.5 What is the difference between generic and HIV-specific outcome measures?

Table 5.5: Advantages and Disadvantages of Generic versus Disease-specific Measures

Type of Outcome Measure Advantages and Disadvantages
Generic Measures

These measures can be used with all individuals in the general population.

If a generic measure is used with people living with HIV, their scores can be compared with people living with other types of illness who completed that same measure, or even to the general ‘healthy’ population.

Examples of generic measures commonly used in HIV practice and research include:

  • Medical Outcomes Study Short Form (SF-36) questionnaire, which measures health-related quality of life (HRQL)1,2
  • Assessment of Motor and Process Skills (AMPS), which is used to measure safety, independence, efficiency and effort when performing daily life tasks within and around the home3,4
  • Centre for Epidemiological Studies for Depression Scale (CES-D), which measures depression5
  • One drawback with generic measures is that there may be unique aspects related to HIV that are not captured in a generic type of measure (e.g., lipodystrophy, HIV stigma and discrimination, and fear of disclosure).
Disease-Specific Measures

These can measure a health- related concept within a specific disease group (e.g., people living with HIV).

To capture disease-specific issues, researchers developed disease or HIV-specific measures to measure the extent of certain health constructs of interest for people living with HIV.

Examples of HIV-specific measures are:

  • HIV Symptom Index, a 21-item self-reported questionnaire that measures symptom presence and severity6
  • Medical Outcomes Study-HIV Health Survey which was adapted from the Short Form 36 (SF-36) to measure HRQL specifically for people living with HIV measuring the presence, severity and episodic nature experienced by adults living with HIV7-9
  • HIV Disability Questionnaire (HDQ), a 69-item self- administered questionnaire describing the presence, severity and episodic nature experienced by adults living with HIV10-14

1 Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9. Review. PubMed PMID: 11124729.

2 Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998 Nov;51(11):903-12. PubMed PMID: 9817107.

3 Fisher A.G., Bray Jones K: Assessment of Motor and Process Skills. Vol. 1: Development, tandardization, and Administration Manual (7th ed.) Fort Collins, CO: Three Star Press; 2010a.

4 Fisher A.G., Bray Jones K. Assessment of Motor and Process Skills. Vol. 2: User Manual (7th ed.) Fort Collins, CO: Three Star Press; 2010b.

5 Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Measure. 1977;1(3):385-401.

6 Justice AC, Holmes W, Gifford AL, Rabeneck L, Zackin R, Sinclair G, Weissman S, Neidig J, Marcus C, Chesney M, Cohn SE, Wu AW; Adult AIDS Clinical Trials Unit Outcomes Committee.

Development and validation of a self-completed HIV symptom index. J Clin Epidemiol. 2001 Dec;54 Suppl 1:S77-90. PubMed PMID: 11750213.

7 Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res. 1997a Aug;6(6):531-54. Review. PubMed PMID: 9330553.

8 Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res. 1997b Aug;6(6):481-93. Review. PubMed PMID: 9330549.

9 Wu AW, Rubin HR, Mathews WC, Ware JE Jr, Brysk LT, Hardy WD, Bozzette SA, Spector SA, Richman DD. A health status questionnaire using 30 items from the Medical Outcomes Study.

Preliminary validation in persons with early HIV infection. Med Care. 1991 Aug;29(8):786-98. PubMed PMID: 1875745.

10 O’Brien KK, Davis AM, Gardner S, Bayoumi AM, Rueda S, Hart TA, Cooper C, Solomon P, Rourke SB, Hanna S; OHTN Cohort Study Team. Relationships Between Dimensions of Disability Experienced by Adults Living with HIV: A Structural Equation Model Analysis. AIDS Behav. 2012 Nov 7. [Epub ahead of print] PubMed PMID: 23132208.

11 O’Brien KK, Bayoumi AM, Bereket T, Swinton M, Alexander R, King K, Solomon P. Sensibility assessment of the HIV Disability Questionnaire. Disabil Rehabil. 2013 Apr;35(7):566-77. doi: 10.3109/ 09638288.2012.702848. Epub 2012 Jul 21. PubMed PMID: 22816434.

12 O’Brien KK, Solomon P, Bayoumi AM. Measuring disability experienced by adults living with HIV: assessing construct validity of the HIV Disability Questionnaire using confirmatory factor analysis. BMJ Open. 2014 Sep 1;4(8):e005456. doi: 10.1136/bmjopen-2014-005456. PubMed PMID: 25180054; PubMed Central PMCID:PMC4156819.

13 O’Brien KK, Solomon P, Bergin C, O’Dea S, Stratford P, Iku N, Bayoumi AM. Reliability and validity of a new HIV-specific questionnaire with adults living with HIV in Canada and Ireland: the HIV Disability Questionnaire (HDQ). Health Qual Life Outcomes. 2015 Aug 12;13:124. doi: 10.1186/s12955-015-0310-9. PubMed PMID: 26263898; PubMed Central PMCID: PMC4542093.

14 O’Brien KK, Bayoumi AM, Stratford P, Solomon P. Which dimensions of disability does the HIV Disability Questionnaire (HDQ) measure? A factor analysis. Disabil Rehabil. 2015;37(13):1193-201. doi: 10.3109/09638288.2014.949358. Epub 2014 Aug 13. PubMed PMID: 25116628.

Primary Sidebar

Copyright © 2025 · Realize Canada